Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
Fondaparinux is a synthetic pentasaccharide which targets Factor Xa. It has the advantage of a single daily dose (2.5 mg) and less bleeding with equal efficacy. This has been proved by OASIS 5 trial in unstable angina & non-ST elevation myocardial infarction and OASIS 6 trial in ST elevation myocardial infarction.
